References
- Sobeslavsky O. Prevalence of markers of hepatitis B in various countries: a WHO collaborative study. Bull WHO 1980; 58: 621–628
- Maynard J E. Hepatitis B: global importance and need for control. Vaccine 1990; 8: S18–20
- Struwe J, Giesecke J, Olcén P, von Sydow M, Weiland O. The prevalence of hepatitis B virus markers in Sweden: a community-based serosurvey of 4000 young Swedish adults. Am J Epidemiol 1992; 135: 409–417
- Sung and the Asian Regional Study Group. Hepatitis B virus eradication strategy for Asia. Vaccine 1990; 8: S95–S99
- Kiire and the African Regional Study Group. Hepatitis B infection in sub-Saharan Africa. Vaccine 1990; 8: S107–S112
- Christenson B. Epidemiology of hepatitis B in Sweden. J Infect 1987; 15: 269–277
- Christenson B. Antalet smittbärare med hepatit B ökar medan akutfallen minskar. Läkartidningen 1990; 87: 2745–2746
- Szmuness W. Hepatocellular carcinoma and hepatitis B virus: evidence for a causal association. Prog Med Virol 1978; 24: 40–69
- Beasley R P, Hwang L Y, Lin C C, Chien C S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981; 2: 1129–1133
- Viola L A, Barrison I G, Coleman J C, Paradinas F J, Fluker J L, Evans B A, Murray-Lyon I M. Natural history of liver disease in chronic HBsAg carriers. Lancet 1981; 2: 1156–1159
- Sakuma K, Takahara T, Okuda K, Tsuda F, Mayumi M. Prognosis of HBsAg carriers in relation to routine liver function tests – a prospective study. Gastroenterology 1982; 83: 114–117
- Alward W LM, McMahon B J, Hall D B, Heyward W L, Francis D P, Bender T R. The long-term serological course of asymptomatic hepatitis B virus carriers and the developement of primary hepatocellular carcinoma. J Infect Dis 1985; 151: 604–606
- Dragosics B, Ferenci P, Hitchman E, Denk H. Longterm follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria. Hepatology 1987; 7: 302–306
- Hoofnagle J H, Shafrizt D A, Popper H. Chronic type B hepatitis and the healthy carrier state. Hepatology 1987; 7: 758–763
- Popper H, Shafritz D A, Hoofnagle J H. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987; 7: 764–772
- Hall A J, Alveyn C G, Winter P D, Wright R. Mortality of hepatitis B-positive blood donors in England and Wales. Viral hepatitis and liver disease, A J Zuckerman. Alan R Liss Inc, New York 1988; 192–194
- Liaw Y F, Tai D I, Chu C M, Chen T J. The developement of cirrhosis in patients with chronic type B hepatitis. Hepatology 1988; 8: 493–496
- Fattowich G, Brollo L, Alberti A, Guiliano G, Pontisso P, Realdi G, Roul A. Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication. J Hepatology 1990; 11: 29–33
- Kalayci C, Johnson P J, Davies S E, Williams R. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 1991; 12: 54–59
- Hadziyannis S J, Lieberman H M, Karvountzis G G, Shafritz D A. Analysis of liver disease, nuclear HBcAg, viral replication, and HBV DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus. Hepatology 1983; 3: 656–662
- Papaevangelou G, Tassopoulos N, Roumeliotou-Karyannis A, Richardson S C. Sexual transmission of hepatitis B virus. J Infect Dis 1985; 152: 231
- Krogsgaard K, Wantzin P, Aldershvile J, Kryger P, Andersson P, Nielsen J O. Hepatitis B virus DNA in HBsAg-positive blood donors: relation to HBe-system and outcome in recipients. J Infect Dis 1986; 153: 298–303
- Lee H S, Chung Y H, Kim C Y. Specificities of S-AFP in HBsAg+ and HBsAg– patients in the diagnosis of hepatocellular carcinoma. Hepatology 1991; 14: 68–72
- Alpert E, Omata M, McMahon B J, Wainwright R B. Early detection of hepatocellular carcinoma. Viral hepatitis and liver disease, F B Hollinger, S M Lemon, H S Margolis. Williams & Wilkins, Baltimore 1991; 884–889
- MMWR. Screening for HBV infection among refugees arriving in the USA 1979–1991. MMWR 1991; 40: 784–786